The enteric nervous system (ENS) in mammals is derived from a small pool of progenitor cells, namely enteric neural crest cells (NCCs). These precursor cells proliferate extensively to expand, migrate over a long distance to fully colonize the developing gut and differentiate into millions of neurons and glia to form a functional ENS for regulating the complex behaviors of the gut. This developmental process relies on a precise regulation of the neuronal and glial differentiation and requires an appropriate balance between the migration, proliferation and differentiation of enteric NCCs and their progeny. Hedgehog (Hh) and Notch signalings are essential for almost every aspect of ENS development, and they confer both the long-and short-range signals to coordinate these seemingly diverse cellular processes. In this review, we summarize the roles of Hh and Notch signaling, particularly in the context of gut organogenesis and ENS development and emphasize how combinatory Hh and Notch signaling renders functional diversity as well as specificity.
Introduction
The enteric nervous system (ENS) in mammals is derived from a small pool of enteric neural crest cells (NCCs). These precursor cells extensively proliferate to expand, migrate over a long distance to fully colonize the developing gut, and differentiate into millions of neurons and glia which are organized into a network to coordinate bowel movement. This developmental process relies on a precise regulation of the neuronal and glial differentiation, and requires an appropriate balance between the proliferation and differentiation of enteric NCCs and their progeny. Different combinations of long-and short-range instructive signals are implicated in various stages of NCC development that occur over a lengthy period of time. At early stages, these signals are involved in NCC specification and delamination and extend further into later stages for supporting gut colonization and formation of a functional neural network. As for ENS development, many of these signals originate from the gut mesenchyme, through the production of secretory molecules to activate their downstream molecular events in enteric NCCs that are distant from the origin of the signals. Alternatively, a short-range signaling is established where signaling molecules are secreted by enteric NCCs and target themselves or their neighboring cells. Hedgehog (Hh) is one of the key morphogens expressed in gut mesenchyme, establishing various concentration gradients across the developing gut to offer the long-range regulation. Notch, on the other hand, is expressed by the enteric NCCs and acts on the adjacent cells functions through lateral inhibition or activation. Compelling evidence suggests that Hh and Notch signaling play equally important roles in ENS development. In this review, we focus on Hh and Notch signaling and emphasize how Hh and Notch work coordinately regulate ENS development.
Enteric Nervous System
ENS is mainly derived from vagal NCCs and partly from sacral NCCs. These progenitors move along the gut in a rostrocaudal manner and gradually colonize the developing gut. In addition to rostrocaudal migration, Nishiyama et al. [1] have recently shown that indeed a population of enteric NCCs migrates from the midgut to the hindgut via the mesentery (transmesenteric migration) and these transmesenteric NCCs contribute a large part of the hindgut ENS. Sacral NCCs, on the other hand, are only responsible for a small fraction of ENS in the distal midgut and hindgut, and their migration is apparently independent of that of the vagal NCCs [2] . While ENCCs are migrating, they also proliferate and progressively give rise to neurons and glia which are organized into ganglia and are localized in the two main plexuses. The outer myenteric plexuses are found between the longitudinal and circular muscle layers, and the inner submucosal plexuses reside within the submucosa of the intestine. These two plexuses are symmetrically interconnected to form a functional neuronal network to control motility, fluid exchange and gut hormone secretion [3, 4] .
Proliferation, Differentiation and Migration of Enteric NCCs
Proper control of population size of pre-enteric NCCs is one of the key steps that determine their capacity to fully colonize the gut and to give rise to a full diversity of neurons and glia. When the total number of avian vagal NCCs was experimentally reduced by ablation of the dorsal neural tube in the vagal region, enteric NCCs failed to fully colonize the whole gut accompanied by a reduced number of neuronal subtypes [5] . Similarly, in mice, proliferation of enteric NCCs at the migratory wavefront was shown to be the main driving force for these cells to invade the intestine [6, 7] . Therefore, correct population sizes of pre-enteric and enteric NCCs are critical for complete colonization of the gut.
Neurogenesis and gliogenesis are two highly coordinated developmental processes for generation of neurons and glia in ENS. Despite that there being a considerable overlap between the periods of enteric neurogenesis and gliogenesis, neurogenesis usually occurs first and overt gliogenesis is apparent slightly later. In mice, neuronal progenitors can be detected as early as E10-E10.5 just behind the migratory wavefront of the enteric NCCs [8] .
These enteric progenitors generate new neurons throughout embryogenesis and even beyond P30. Nevertheless, only very limited neurogenesis occurs in the adult gut under steady-state conditions and adult ENS, unlike CNS, does not have constitutive neurogenesis by dividing progenitors [9, 10] . The first glial precursors appear at around E11.5-E12 [11] , and mature glial cells provide support and insulation for the enteric neurons, as well as being a scavenger to clear apoptotic cells [12] . More recently, it has been reported that neurogenesis occurs from a rare population of glial cells in the adult ENS upon injury induced by neurotoxic detergent (benzalkonium chloride) [9, 10] . However, it is still not clear what kind of injuries might occur under physiological conditions that can induce neurogenesis of ENS. Overall, the adult ENS just has a low-level turnover of enteric glia under steady-state conditions as well as considerable regenerative capacity to form glia after injury, which would be crucial for the maintenance of ENS function.
Hirschsprung's Disease
Hirschsprung's (HSCR) disease is a congenital ENS defect and is attributed to a failure of enteric NCCs to colonize the hindgut, leading to lack of ganglion cells along varying segments of the intestine. HSCR patients usually exhibit abnormal bowel contraction or obstruction that leads to food bolus accumulation and severe constipation. HSCR exhibits multifactorial modes of inheritance and more than 14 genes have been identified associated with HSCR, but mutations in these genes are of incomplete penetrance and account for only 50% of the familial and up to 20% of the sporadic cases [13] . More recently, genome-wide association study (GWAS) conducted on HSCR patients has uncovered many more new disease loci and provided valuable insights into the contribution of structural variants to HSCR [14] [15] [16] [17] . Intriguingly, many of these genetic variants/mutations are found in genes such as RET, NEUREGULIN 1 and 3 , PATCHED1 and DELTA-LIKE3 that regulate the proliferation, migration or differentiation of enteric NCCs, highlighting the relevance of these genes in ENS development and HSCR pathogenesis. Till now, still little is known about the underlying mechanisms and how dysregulation of these genes may lead to HSCR disease. Therefore, the important next step is to convert novel genetic findings into the knowledge needed for a better understanding of disease mechanisms.
Hh Signaling Pathway

Signal Transduction Machineries of Hh Pathway
Hh is crucial for both embryogenesis and tumorigenesis in mammals and has been implicated in many human diseases. The Hh pathway can be activated by one of their three homologues of the Drosophila proteins, namely Sonic hedgehog (Shh), Desert hedgehog (Dhh) and Indian hedgehog (Ihh), of which Shh is the best characterized signaling protein involved in the early patterning and cell fate specification in various systems [18] .
The fundamental machinery of Hh signal transduction involves three Gli proteins. For Hh signal activation, two transmembrane proteins including a receptor Patched (Ptch) and a signal activator Smoothened (Smo) are required. In the absence of Hh ligand, Ptch constitutively represses Smo activity. Upon binding of Hh, Ptch relieves its inhibition of Smo and activates downstream events. In mammals, membrane trafficking of Ptch and Smo is critical for Hh signaling. Receptor endocytosis of Ptch is implicated in shaping the signal gradient [19, 20] , while Smo trafficking to the primary cilia is required for Hh signal transduction [21] . The downstream signal activation of Hh pathway is mainly mediated by a family of zinc-finger-containing transcriptional factors, Gli proteins (Gli1, Gli2 and Gli3) [22] . Gli1 and Gli2 function mainly as transcriptional activators, whereas Gli3 is a principle repressor. Both Gli2 and Gli3 are present in two forms: a full-length transcription activator (Gli A ) and a truncated aminoterminal fragment with repressive activity (Gli R ). In the absence of Hh, Gli2 and Gli3 exist as a part of the protein complex in cytoplasm and are tethered to the microtubules. Proteolytic cleavage of the full-length Gli generates Gli R , which enters the nucleus to suppress the Hh target genes. In the presence of Hh, active Smo blocks the proteolysis of Gli and generate Gli activator (Gli A ). Different Hh levels result in unique Gil A /Gli R ratios, by which distinct sets of Hh target genes are switched on or off, conferring a gradient of Hh responses [23] .
Primary Cilium in Hh Signaling Transduction
Primary cilium is a microtubule-based non-motile organelle that emanates from the cell surface of quiescent cells. It acts as a sensory organelle to coordinate various signaling pathways, which are critical in both embryonic development as well as tissue homeostasis in adulthood. Assembly of the cilia is mediated by intraflagellar transport (IFT), by which large complexes called IFT particles are moved from the basal body into and along the ciliary microtubules. Integrity of cilia is essential for mammalian Hh signal transduction [24] . As summarized in figure 1 , in the absence of Hh ligand, the Ptch receptor resides in the ciliary membrane and prevents Smo from entering primary cilia. Upon stimulation by Hh ligand, Ptch exits the cilium and consequently triggers the ciliary accumulation of active Smo [25] . Translocation of Gli to the ciliary tip is also induced by Hh signal, so Gli proteins accumulate at ciliary tips after pathway activation. Furthermore, active Smo progressively activates the full-length Gli proteins to Gli A and induces the microtubule-dependent translocation of Gli to the nucleus to activate transcription of Hh target genes [26, 27] . Defective ciliary assembly or function results in an attenuated Shh pathway, leading to an array of congenital diseases in humans.
Hh Signaling Components in the Developing Gut
In all mammals examined, Shh , Ihh and Dhh are expressed in the developing gut tube. Shh and Ihh are expressed in the epithelium, while Dhh is specifically expressed in Schwann cells, peripheral nerves and endothelial cells. In mouse, during gut organogenesis, Shh and Ihh are co-expressed in gut primitive endoderm epithelium at early somite stage (8.5 dpc) before the enteric NCCs reach the stomach that usually occurs at E10.5. At the later stages, from the early stomach development (E10) to the initiation of epithelial cytodifferentiation at E15.5, Shh and Ihh are persistently, but differentially expressed in the developing guts. Shh remains its high level expression in the forestomach and lower level in the hindgut, whereas Ihh expression is more restricted to the posterior stomach. By E14.5, Shh expression in the small intestine is downregulated while Ihh expression remains. In E18.5 gut, Shh expression appears to be re-upregulated and highly expressed in the glandular stomach, small intestine, and colon, but its expression is mostly restricted to colonic crypts [28] . Expression of Ptch1 is localized in the mesoderm and mirrors that of Shh , but not for Ihh . There is only very low expression of Ptch1 in the distal stomach, it suggests that Ihh may not be translated or remains inactive at early stage. More recently, the temporal and spatial expression of Hh components including Ptch1, Gli1, Gli2, and Gli3 are better defined with various Gli reporter mouse lines. Mo et al. [29] have nicely demonstrated the dynamic alteration of Hh activity in the stomach and intestine, further supporting the presence of high Hh activity domain in the stomach versus low Hh activity in the intestine. Importantly, the expressions of the other key Hh signal transduction machineries such as Ptch1, Smo, Gli1, Gli2, and Gli3 have demonstrated in enteric NCCs, highlighting the relevance of Hh signal in the ENS development [16, 30] .
Hh Signaling in Enteric NCC Development
Implications of Hh signaling in ENS development have been directly demonstrated in various model systems. In the zebrafish, Shh expression is first detected at the anterior end of the intestine, while Ptch1 is widely expressed throughout the mesenchyme adjacent to the endoderm and is expressed by enteric NCCs. Shh is essential for the migration of enteric NCCs from the vagal region to the anterior end of the intestine in both the pre-enteric phase and an enteric phase. No migrating enteric NCCs were observed when Hh signaling was attenuated either by cyclopamine or in the hedgehog pathway homozygous mutants: sonic you (syu) , that has a deletion in the Shh gene, and smooth muscle-omitted (smu) , that has a mutation in ENCC migration/patterning 2 1 Neurogenesis and gliogenesis A then moves to the nucleus by the microtubule-dependent transport system and triggers gene transcription. Delta ligands (Dll1 and Dll3) are expressed in the surface of signaling sending NCCs, and subsequently bind to the Notch receptor which is expressed in the neighboring cells. Upon binding of ligand to the receptor, the receptor is subjected to two proteolytic cleavages (S2 and S3 cleavages) mediated by ADAM10/7 and γ-secretase, respectively, and lead to generation of free Notch intracellular domain (NICD). NICD enters the nucleus and interacts with CSL (e.g. RBP-J) to activate the transcription of Notch target genes, such as Hes family genes. GDP-fucose protein O-fucosyltransferase 1 (Pofut1) is essential for the cell surface expression of Notch receptor. Hh and Notch pathway genes implicated in various aspects of ENS development are summarized in the lower panel.
zebrafish Smo . In the pre-enteric phase, Shh likely acts either directly or indirectly, via regulating the production of glial cell line-derived neurotrophic factor (Gdnf), to direct the vagal neural crest-derived enteric NCC to the anterior end of the intestine. However, during the enteric phase of ENS development, the key activity of Shh on ENS precursors is as a mitogen rather than as an indirect regulator of ENS precursors' migratory ability [31] .
Similarly, in the avian system, Shh secreted from the endodermal epithelium is also essential for the gut development. Inhibition of the Shh signaling by cyclopamine results in an ectopic formation of enteric neurons accompanied by an increased differentiation of smooth muscle cells in chick gut explants. Particularly, the severity of the patterning defect and aganglionosis is positively correlated to the concentration of cyclopamine being used, suggesting the relevance of the graded activity of Hh in enteric neuron formation [32, 33] .
Hh signaling in mouse ENS development is also indispensable and mouse mutants carrying mutations in various Hh components consistently exhibit ENS defects as summarized in figure 1 . Both Shh -/-and Ihh -/-mouse mutants exhibit severe ENS defects despite with distinct phenotypes. In Shh null, enteric NCCs are still able to migrate along and fully colonize the developing gut. However, ectopic formation of ganglions is observed in the stomach and small intestine, where a substantial number of neurons are found differentiating abnormally in the epithelium of villi. Ihh -/-mutants, on the other hand, exhibit totally different phenotypes, in which 50% of the mutants display HSCR-like phenotypes with absence of ganglions in the distal regions of colon [28] . The incomplete penetrance of the phenotypes suggests that other factors or modifier genes are likely involved in determining the severity of the phenotypes. Given the overlapping distribution and functional redundancy between Shh and Ihh, removal of both Shh and Ihh is required in order to precisely define the function of Hh proteins in gut organogenesis and ENS development. Shh -/-; Ihh -/-double mutant mouse displays more severe phenotypes which dies at E8.5, precluding an analysis of ENS development. More recently, the Cre/loxP system has been applied to delete Shh and Ihh specifically in the early gut endoderm. Mutants with conditional ablation of Shh and Ihh consistently exhibit severe ENS phenotypes. Despite the fact that some enteric neurons still exist in the stomach at E12.5 and E16.5, the number of neurons is noticeably diminished [34] . The analyses of single and double mutants reflect that Shh and Ihh are critical for ENS development, but probably in different aspects. It is also important to note that the N-terminal signaling peptides of Shh and Ihh exhibit more than 90% amino acid sequence homology, and both bind to Ptch1 and activate the Hh signaling cascades of the responsive cells with a similar mechanism. However, how inactivation of these two similar genes leads to such different phenotypes and what are the underlying mechanisms for Shh and Ihh to differentially regulate ENS development remain to be fully elucidated.
Cell autonomous action of Hh in enteric NCCs has also been demonstrated using the enteric NCC culture, where Shh negatively regulates the migration and neuronal differentiation of enteric NCCs. Pretreatment of enteric NCCs with Shh abolishes Gdnf-induced neuronal differentiation and migration [30] . A subsequent study demonstrates that Shh indeed only transiently promotes the proliferation of enteric NCCs, while constitutive activation of the Hh pathway by deletion of Ptch1 or long-term treatment with Shh or its agonist (purmorphamine) favors the differentiation of enteric NCCs towards the glial lineage. Conditional ablation of Ptch1 in NCCs results in premature gliogenesis and a reduced number of ENS progenitors, through activation of the Notch signaling pathway. Intriguingly, epistasis analysis of genetic data generated from a GWAS on HSCR patients further reveals that PTCH1 represents a susceptibility gene for HSCR disease and cumulative effects of variations in PTCH1 and DLL3 confer a higher risk to HSCR. This study has defined a potential disease mechanism that glial mediators may contribute to the pathogenesis of HSCR [16] .
Gli1, Gli2 and Gli3 are the transcription factors mediating Hh signaling output. Multiplicity of Gli proteins allows a two-tiered control of Hh signal transduction, where Gli2 and Gli3 are the primary transducers, and Gli1 acts as the secondary transducer refining Hh signaling. Like in other systems, Gli1 is a direct Hh target gene in enteric NCCs and activation of Hh signaling by deletion of Ptch1 or addition of Shh or its agonist robustly upregulates Gli1 expression [16] . Although Gli1 -/-mice do not show any severe developmental defect [35, 36] , the implication of Gli1 in ENS development has been demonstrated in an early study with ectopic overexpression of human GLI1 gene in transgenic mice. Transgenic mice of ectopic expression of GLI1 display a HSCR-like phenotype and severity of the phenotype is directly associated with the expression level of GLI1 transgene [38] . In addition, Gli1 expression is strictly regulated by Gli2 and Gli3 in early mouse embryo, so Gli2 and/or Gli3 are likely the key transcription factor(s) for Hh activity. The expression pattern of Gli2 is similar to that of Gli1, but the expression level of Gli2 transcripts in enteric NCCs is low and no obvious upregulation of Gli2 has been detected upon Hh stimulation in vitro [unpubl. data] . In addition, with the mouse reporter line the Gli2 signal is barely detectable in enteric neurons at E14.5 in mice [37] . Thus, the role of Gli2 in ENS development is still elusive. Gli3, on the other hand, is highly expressed in the enteric NCCs including both activator (Gli3 A ) and repressor (Gli3 R ) forms. As deletion of Ptch1 in enteric NCCs results in a reduced expression of Gli3 R [16] , the primary role for Hh signaling activity is likely to inhibit the formation of Gli3 R in enteric NCCs. Recent advances in gene targeting have deepened our knowledge about Hh signaling and the presence has been suggested of distinct Hh activity domains in the developing gut of a high Hh level in the stomach versus a low level in the intestine. The differential Hh activity domains may result in the formation of a distinct Gli activator to repressor ratio (Gli A /Gli R ) in the stomach versus intestine, such that Hh would further confer the context-dependent gene regulation and generate the graded Hh responses along the developing gut. Different experimental approaches that specifically remove or overexpress the Gli A or Gli R will be necessary to unambiguously reconcile whether graded Hh signaling plays any patterning role during colonization of stomach and intestine.
The second line of evidence supporting the involvement of Hh signaling in ENS development relies on the close association between ENS defects and various Shh-dependent craniofacial defects. Bardet-Biedl syndrome (BBS) is a primary ciliopathy with IFT dysfunction and characterized by facial dysmorphology. Twelve BBS genes (BBS1-BBS12) have been identified so far and mutations in these genes cause primary cilia dysfunction [39] . HSCR disease represents a component feature associated with BBS, so it has been suggested that these two diseases share a common genetic basis. Studies in zebrafish indicated that Bbs8 morphant embryos are reminiscent of Shh pathway mutants or cyclopamine-treated fish embryos and exhibit a blunted response to Hh stimuli of a significant reduction of Ptch1 and Gli1 expression accompanied by an accumulation of Gli3 R . These Hh-deficient fishes recapitulate human disease phenotypes and display both craniofacial and ENS defects [40] . Concordant data has been obtained recently by Tu et al. [41] . They have knocked down a major intracellular trafficking regulator called ADP ribosylation factor-like 6 interacting protein 1 (Arl6rip1) in zebrafish and the Arl6rip1 morphant fishes display HSCR-associated BBS-like phenotypes. Loss of Arl6rip1 dampens Shh signaling and leads to migration defects of vagal NCCs, resulting in incomplete colonization of the gut.
Notch Signaling
Signal Transduction Machineries of the Notch Pathway
Notch signaling is highly conserved among different species with a well-defined framework. Like Hh, Notch is one of the most pivotal developmental signals in mammals and aberrant Notch signaling has been implicated in varying human diseases. Four Notch receptors (Notch1-4) and their ligands Delta (Delta1-4) and Serrate/Jagged (Jagged1-2) are transmembrane domain proteins. Upon ligand stimulation, Notch receptor will undergo proteolytic cleavage by two steps -S2 and S3 cleavages. S2 cleavage is mediated by the ADAM family, followed by a second cleavage through the γ-secretase complex (S3 cleavage). These cleavages lead to the generation of a free intracellular domain (NICD), which subsequently translocates into the nucleus and binds to the DNA-binding proteins CSL (e.g. Su(H), CBF and RBP-Jk) to initiate the transcription of various target genes including Hes1 . Hes1 is a transcriptional repressor and it negatively regulates its downstream targets, such as Mash1, neurogenin (Ngn) or MyoD to maintain progenitor cells from differentiation [42] ( fig. 1 ) .
Notch Signaling Components in the Developing and Adult Guts
The expressions of Notch signaling components in mouse developing gut have been well described. At E11.5, Notch1 , Dll1 and Dll3 are expressed in the majority of enteric NCCs, but only few cells express Notch4 , Dll4 and Jag [43] . Notch1-3 is highly expressed in the endoderm and mesenchyme at E12.5, but Notch4 is absent at these stages. Higher Hes1 expression is detected in endoderm when compared to its expression in mesenchyme, indicating a more active Notch signaling is present in the endoderm. Notch ligands Jag1 and Dll3 are also expressed in the mesenchymal cells [44] . In the rat adult ENS, Notch1 and Jag2 are specifically expressed in non-proliferating ganglion cells located in the myenteric and submucosal plexuses. Notch1 expression is detected only in one half of all myenteric neurons. It is preferentially expressed in the cholinergic neurons, but is absent in the nitric oxide synthase and calretinin-immunoreactive neurons. Jag2 expression, on the other hand, is detected in most of the neurons [45] . This observation raises a possibility that Notch1 has a role in specifying and maintaining cholinergic neurons, while Jag2 functions in the maintenance of all types of neuronal cells in the adult ENS. It is also consistent with an observation that reduced expression of NOTCH1 and JAG2 are detected in the aganglionic segments of HSCR bowel [46] .
Notch Signaling in Enteric NCC Development
Deletion of Notch1 , Notch2 , Jag1 , or Dll1 in mouse are embryonic lethal and mutants die at the early stage before ENS development starts [47] [48] [49] [50] , while Notch3 , Notch4 , or Dll3 null show mild phenotypes and no obvious NC-associated defect is observed [51] [52] [53] . Subsequent studies using conditional genetic ablation of different Notch signaling components have clearly dissected the peculiar roles of Notch signaling in various aspects of ENS development (table 1) . For instance, genetic ablation of Rbpj in mouse NCCs causes defects in glial specification or differentiation leading to a significant reduction in number of enteric glia and neurons. Interestingly, at E10.5, comparable numbers of enteric progenitors were found in the mutant and control guts and the mutants do not show any depletion of pre-migratory NCC progenitors, suggesting that loss of Rbpj does not affect the capability of enteric NCCs to colonize the gut. However, a significant reduction in the number of neurons and glia is observed at E14.5 and this reduction persists through to E18.5. In addition, Taylor et al. [54] show that Rbpj-deficient enteric NCCs exhibit a similar proliferation rate in vivo, but the frequency of mutant cells to form multiple lineage colonies in culture is threefold lower than the control. Therefore, it is possible that Rbpj may not only be required for the glial lineage differentiation but also for the maintenance of undifferentiated ENS progenitors. Notch signaling is also implicated in NCC migration, where deletion of Dll1 leads to defects in NCC migration. Dll1-deficient NCCs lose their rostral-caudal polarity and the mutant cells are randomly distributed rather than following the normal migratory path [55] . A more recent study with conditional gain of Notch signaling (Wnt1Cre;Rosa Notch ) in NCCs has revealed that the aberrant Notch signaling leads to ENS defects through interrupting the migratory pathway of NCCs. Ectopic activation of Notch signaling in the pre-migratory NCCs disrupts the normal migratory route of NCCs, in which migrating NCCs are organized into two distinct streams but instead migrate in a bulk population. Although the enteric NCCs of Wnt1Cre;Rosa Notch mutants still retain their capacity to colonize the gut, the number of enteric NCCs is markedly reduced and there is almost complete absence of NCCs in the midguts of these mutants [56] . In the context of NCC differentiation, Notch signaling is also indispensable and implicated in both inhibiting neurogenesis and promoting the gliogenesis. Treatment of enteric NCCs with Dll1 robustly induces Notch receptor cleavage accompanied by accumulation of NICD and Hes1, leading to the elevated expression of various glial markers, such as S100β and GFAP and loss of neurogenic plasticity. Furthermore, Notch signaling likely subserves a similar role in mouse and human. NCCs isolated from human skin, also called skin-derived progenitors (SKPs), show similar propensity to give rise to cells expressing glial markers when they are exposed to DLL1 [16] . Similarly, when the Notch signal is inhibited, enteric NCCs undergo premature neurogenesis. Protein O-fucosyltransferase 1 (Pofut1) functions upstream of NICD and is responsible for the Notch-Delta interactions and trafficking of the Notch receptor [57, 58] . Mouse mutants with NCC-specific ablation of Pofut1 show a premature neurogenesis of enteric NCCs and reduced glial progenitors. Moreover, Sox10 expression is profoundly downregulated in the Pofut1 mutant embryos at E11.5 and is even completely absent at E12.5, implying that Notch signaling promotes gliogenesis through mediating Sox10 expression [43] . Intriguingly, Notch and Sox10 contribute to both the maintenance of ENS progenitors and promoting gliogenesis, an additional regulatory mechanism is likely involved in different Delta-1 -/-Depletion of the enteric NCCs p recursor pool Abnormal migratory route [55] developmental stages to confer the dual functions of Notch and Sox10 in these two processes. In addition to positive regulation of Sox10 expression to promote gliogenesis, Notch also simultaneously upregulates Hes1 which subsequently downregulates Mash1 expressions to inhibit neurogenesis. As a negative feedback, the regulatory mechanism between Sox10 and Mash1 has been reported where Sox10 induces Mash1 expression and Mash1 re-suppresses the Sox10 expression [60] . Notch signaling is therefore likely involved in balancing the Sox10 and Mash1 activities to enable a continuous derivation of mature neurons and glia while maintaining a consistent progenitor population [56, 61] .
Combinatorial Action of Hh and Notch Signaling in the Embryonic Gut
The temporal and spatial expression regulation of Hh and Notch ligands and their receptors, graded Hh activity or lateral inhibition/induction of Notch signaling, multiplicity of transcription factors or proteolytic signaling transduction cascades, all confer multiple layers of signal confinement for Hh and Notch signalings. Indeed, combinatorial action of these two signals may further refine the cellular response, where combinations of exposure to these signals would be contemporaneous or occur sequentially.
Interaction between Hh and Notch has been evidenced in various stages of gut development. Firstly, Notch signaling components and their receptors are expressed in close proximity to or co-expressed in the Hh-responsive cells of the gut mesenchyme as well as in the enteric NCCs. The second evidence showing the potential interactions between these two prominent signals is based on the fact that Hh and Notch share the common downstream targets such as Hes1 and Hes5 [44] . More recently, Kim et al. [44] have shown that mouse mutants with excessive Notch or lack of Hh signaling develop similar defects in the stomach mesenchyme, where a significant reduction of enteric neurons and loss of nearly all lamina propria fibroblasts are found. Concordant with these observations, Hh-deficient embryos also show Notch overactivity in their defective gut mesenchyme and exposure to recombinant Shh override Notch-induced death of cultured fetal gut mesenchymal cells [34, 44] . All these data support the notion that endodermal Hh signaling regulates the development of gut mesenchyme at least in part through restraining the level of Notch activity. Regarding the ENS development, Notch and Hh signaling are found interacted at both genetic and functional levels and contribute to ENS development and HSCR pathogenesis. Ngan et al. [16] have performed a canonical correlation analysis (CCA) on the data obtained from GWAS with HSCR patients. The data suggests that a combination of certain PTCH1 and DLL3 alleles confers a higher risk to HSCR. Subsequent functional study using mouse mutants with NCC-specific ablation of Ptch1 further indicates that constitutive activation of Hh leads to a robust activation of Notch signaling through inducing Dll1 expression. As a consequence of excessive Hh and Notch signal, the number of enteric progenitors is markedly reduced and associated with premature gliogenesis. This study has highlighted how multiple signals may integrate and lead to diverse cellular responses. In general, Hh signaling acts as a mitogen to promote the cell proliferation, but reduced proliferation of enteric progenitors is observed in the Ptch1 -/-mutants. It would probably be the secondary effect of premature gliogenesis where the Notch signal is likely the key mediator for this process. Therefore, Hh may work cooperatively with Notch signaling to confine the temporal regulation of enteric NCC development including proliferation, the onset of neuronal differentiation and the switch from neurogenesis to gliogenesis [16] .
